Literature DB >> 11346462

A ferulic acid derivative, ethyl 3-(4'-geranyloxy-3-methoxyphenyl)-2-propenoate, as a new candidate chemopreventive agent for colon carcinogenesis in the rat.

B S Han1, C B Park, N Takasuka, A Naito, K Sekine, E Nomura, H Taniguchi, T Tsuno, H Tsuda.   

Abstract

The inhibitory influence of ferulic acid (FA), a rice germ component, and its geranylated derivative 3-(4'-geranyloxy-3-methoxyphenyl)-2-propenoate (EGMP) on the post-initiation stage of azoxymethane (AOM)-induced colon carcinogenesis was studied in male F344 rats given two s.c. injections of AOM (15 mg / kg body weight) during week 1. Diets containing EGMP or FA at doses of 0.1 or 0.2% were then fed for 3 weeks from week 2 to 5, when the animals were sacrificed. The numbers of aberrant crypt foci (ACF) and aberrant crypts (AC) per rat in the group given 0.2% FA were significantly decreased (P < 0.001) as compared to the AOM alone group. Furthermore, the numbers of ACF and AC per rat fed the 0.2% and 0.1% EGMP were significantly reduced (P < 0.001 and P < 0.01, respectively). Colonic epithelial cells in S-phase, as measured by bromodeoxyuridine (BrdU) labeling, in rats fed EGMP were significantly decreased in the 0.2 and 0.1% EGMP groups as compared to the AOM alone group (P < 0.05). BrdU labeling indices in rats fed FA and EGMP assessed by a test using a coefficient for linear contrast were also significantly decreased as compared to the AOM alone value (P < 0.05, P < 0.01, respectively). The results indicate that FA and EGMP have inhibitory effects on ACF and AC development, EGMP being more potent, possibly due to stronger suppressive effects on cell proliferation. No toxic effects were observed in rats given either compound in terms of body and organ weights, and liver or kidney histology. The findings thus suggest that EGMP and FA, especially the former, might have potential as chemopreventive agents against colon tumor development.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11346462      PMCID: PMC5926721          DOI: 10.1111/j.1349-7006.2001.tb01109.x

Source DB:  PubMed          Journal:  Jpn J Cancer Res        ISSN: 0910-5050


  30 in total

1.  Efficacy of potential chemopreventive agents on rat colon aberrant crypt formation and progression.

Authors:  M J Wargovich; A Jimenez; K McKee; V E Steele; M Velasco; J Woods; R Price; K Gray; G J Kelloff
Journal:  Carcinogenesis       Date:  2000-06       Impact factor: 4.944

2.  Effect of vegetable and carotenoid consumption on aberrant crypt multiplicity, a surrogate end-point marker for colorectal cancer in azoxymethane-induced rats.

Authors:  P J Rijken; W G Timmer; A J van de Kooij; I M van Benschop; S A Wiseman; M Meijers; L B Tijburg
Journal:  Carcinogenesis       Date:  1999-12       Impact factor: 4.944

3.  The identification of monoclonality in human aberrant crypt foci.

Authors:  I M Siu; D R Robinson; S Schwartz; H J Kung; T G Pretlow; R B Petersen; T P Pretlow
Journal:  Cancer Res       Date:  1999-01-01       Impact factor: 12.701

4.  Chemoprevention of heterocyclic amine-induced carcinogenesis by phenolic compounds in rats.

Authors:  M Hirose; S Takahashi; K Ogawa; M Futakuchi; T Shirai; M Shibutani; C Uneyama; K Toyoda; H Iwata
Journal:  Cancer Lett       Date:  1999-09-01       Impact factor: 8.679

Review 5.  Role of aberrant crypt foci in understanding the pathogenesis of colon cancer.

Authors:  R P Bird
Journal:  Cancer Lett       Date:  1995-06-29       Impact factor: 8.679

6.  Modifying effects of ferulic acid on azoxymethane-induced colon carcinogenesis in F344 rats.

Authors:  K Kawabata; T Yamamoto; A Hara; M Shimizu; Y Yamada; K Matsunaga; T Tanaka; H Mori
Journal:  Cancer Lett       Date:  2000-08-31       Impact factor: 8.679

Review 7.  Preclinical efficacy evaluation of potential chemopreventive agents in animal carcinogenesis models: methods and results from the NCI Chemoprevention Drug Development Program.

Authors:  V E Steele; R C Moon; R A Lubet; C J Grubbs; B S Reddy; M Wargovich; D L McCormick; M A Pereira; J A Crowell; D Bagheri
Journal:  J Cell Biochem Suppl       Date:  1994

8.  Inhibition of 4-nitroquinoline-1-oxide-induced rat tongue carcinogenesis by the naturally occurring plant phenolics caffeic, ellagic, chlorogenic and ferulic acids.

Authors:  T Tanaka; T Kojima; T Kawamori; A Wang; M Suzui; K Okamoto; H Mori
Journal:  Carcinogenesis       Date:  1993-07       Impact factor: 4.944

9.  Aberrant crypts correlate with tumor incidence in F344 rats treated with azoxymethane and phytate.

Authors:  T P Pretlow; M A O'Riordan; G A Somich; S B Amini; T G Pretlow
Journal:  Carcinogenesis       Date:  1992-09       Impact factor: 4.944

Review 10.  Growth kinetics and chemoprevention of aberrant crypts in the rat colon.

Authors:  M J Wargovich; C Harris; C D Chen; C Palmer; V E Steele; G J Kelloff
Journal:  J Cell Biochem Suppl       Date:  1992
View more
  5 in total

Review 1.  Most effective colon cancer chemopreventive agents in rats: a systematic review of aberrant crypt foci and tumor data, ranked by potency.

Authors:  Denis E Corpet; Sylviane Taché
Journal:  Nutr Cancer       Date:  2002       Impact factor: 2.900

2.  Immunoelectron microscope localization of androgen receptors and proliferating cell nuclear antigen in the epithelial cells of albino rat ventral prostate.

Authors:  Noha Gamal Bahey; Ezzat Abd El-Aziz El-Drieny
Journal:  J Microsc Ultrastruct       Date:  2015-01-19

3.  Synthesis and characteristics of (Hydrogenated) ferulic acid derivatives as potential antiviral agents with insecticidal activity.

Authors:  Guang-Ying Huang; Can Cui; Zhi-Peng Wang; Yong-Qiang Li; Li-Xia Xiong; Li-Zhong Wang; Shu-Jing Yu; Zheng-Ming Li; Wei-Guang Zhao
Journal:  Chem Cent J       Date:  2013-02-14       Impact factor: 4.215

4.  Ferulic Acid: therapeutic potential through its antioxidant property.

Authors:  Marimuthu Srinivasan; Adluri R Sudheer; Venugopal P Menon
Journal:  J Clin Biochem Nutr       Date:  2007-03       Impact factor: 3.114

Review 5.  Tailored Functionalization of Natural Phenols to Improve Biological Activity.

Authors:  Barbara Floris; Pierluca Galloni; Valeria Conte; Federica Sabuzi
Journal:  Biomolecules       Date:  2021-09-07
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.